AffiAB® Anti-Liver Arginase Antibody [JB21-49]
Arginase I (also designated liver-type arginase) , which is expressed almost exclusively in the liver, catalyzes the conversion of arginine to ornithine and urea. Arginase I exists as a homotrimeric protein and contains a binuclear manganese cluster. Arginase II catalyzes the same reaction as arginase I, but differs in its tissue specificity and subcellular location. Specifically, arginase II localizes to the mitochondria. Arginase II is expressed in non-hepatic tissues, with the highest levels of expression in the kidneys, but, unlike arginase I, is not expressed in liver. In addition, arginase II contains a putative amino-terminal mitochondrial localization sequence..
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: P05089 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
JB21-49
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IHC-P, IP
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within Human Liver Arginase aa 273-322 / 322.
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
N/A
Recommended dilutions
WB: 1:500-1:2, 000
; IHC-P: 1:50-1:200
; IP: 1:10-1:50
Molecular Weight
Predicted band size: 35 kDa
Subcellular location
Cytoplasm.
Positive control
Human liver tissue lysates, human liver tissue.